MAT
39
-4
UNP
50
2
AMT
62
-3
MMC
53
-5
RCL
76
7
FAST
46
-4
ROK
50
6
FITB
50
-2
D
33
-2
HAL
53
3
PNR
50
-12
CB
55
-3
KLAC
65
4
AVGO
37
-3
EXR
53
-2
BAC
45
-5
INTC
45
4
ABBV
68
-2
LYB
50
-5
L
69
-3
MAT
39
-4
UNP
50
2
AMT
62
-3
MMC
53
-5
RCL
76
7
FAST
46
-4
ROK
50
6
FITB
50
-2
D
33
-2
HAL
53
3
PNR
50
-12
CB
55
-3
KLAC
65
4
AVGO
37
-3
EXR
53
-2
BAC
45
-5
INTC
45
4
ABBV
68
-2
LYB
50
-5
L
69
-3
Financhill
Back

Sorrento Therapeutics Vs. Keros Therapeutics Industry Stock Comparison

Sell
41

SRNE
Sorrento Therapeutics

Last Price:
0.0100
Seasonality Move:
-14.33%
Sell
25

KROS
Keros Therapeutics

Last Price:
45.41
Seasonality Move:
4.22%
Sell
41
Sorrento Therapeutics (SRNE) is a Sell

Is Sorrento Therapeutics a Buy, Sell or Hold?

  • The current Sorrento Therapeutics [SRNE] share price is $0.0100. The Score for SRNE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRNE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRNE Stock Price Chart

What is Sorrento Therapeutics's stock price today?

  • The Sorrento Therapeutics share price today is $0.0100
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRNE is experiencing selling pressure, which indicates risk of future bearish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

SRNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 46.39 Sell
Chaikin Money Flow: -257982 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.0114 - 0.0114) Sell
Bollinger Bands (100): (0.0083 - 0.0283) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.91 Sell
Relative Strength Index (14 RSI): 36.74 Sell
Chaikin Money Flow: -120480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.18 - 50.06) Sell
Bollinger Bands (100): (50.42 - 64.92) Sell

SRNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.01 Sell
20-day SMA: 0.01 Sell
50-day SMA: 0.01 Sell
200-day SMA: 0.05 Sell
8-day EMA: 0.01 Sell
20-day EMA: 0.01 Sell
50-day EMA: 0.01 Sell
200-day EMA: 0.12 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Sell
20-day SMA: 47.57 Sell
50-day SMA: 52.43 Sell
200-day SMA: 46.94 Sell
8-day EMA: 46.46 Sell
20-day EMA: 48 Sell
50-day EMA: 51.59 Sell
200-day EMA: 50.14 Sell

Sorrento Therapeutics Earnings Growth & SRNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Sorrento Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):